PUBLICATIONS Before 2005

Neurodegeneration: what is it and where are we?

Przedborski S., Vila M. and Jackson-Lewis V.
Journal of Clinical Investigation 111(1):3-10 (2003)

Apoptosis as therapeutic target.

Vila M.
Neurología 18:186-193 (2003)

Pathogenic role of glial cells in Parkinson’s Disease.

Teismann P., Tieu K., Cohen O., Choi D.K., Wu D.C., Marks D., Vila M., Jackson-Lewis V. and Przedborski S.
Movement Disorders 18(2):121-9 (2003)

Targeting programmed cell death in neurodegenerative diseases.

Vila M. and Przedborski S.
Nature Reviews in Neuroscience 4(5):365-75 (2003)

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson’s disease.

Przedborski S. and Vila M.
Annals of the New York Academy of Sciences 991:189-98 (2003)

COX-2 and Neurodegeneration in Parkinson’s Disease.

Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jackson-Lewis V. and Przedborski S.
Annals of the New York Academy of Sciences 991:272-7 (2003)

The rotenone model of Parkinson’s disease.

Perier C., Bové J., Vila M. and Przedborski S.
Trends in Neuroscience 26(7):345-6 (2003)

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Dauer W., Kholodilov N., Vila M., Trillat A.C., Goodchild R., Larsen K., Staal R., Tieu K., Schmitz Y., Yuan C.A., Jackson-Lewis V., Hersch S., Sulzer D., Przedborski S., Burke R. and Hen R.
Proceedings of the National Academy of Sciences USA 99:14524-14529 (2002)

Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS.

Guegan C., Vila M., Teismann P., Chen C., Onténiente B., Li M., Friedlander R.M. and Przedborski S.
Molecular and Cellular Neuroscience 20(4):553-562 (2002)

Increased Expression and Redistribution of the Antiapoptotic Molecule Bcl-x(L) in Parkinson’sDisease.

Hartmann A., Mouatt-Prigent A., Vila M., Abbas N., Perier C., Faucheux B.A., Vyas S. and Hirsch E.C.
Neurobiology of Disease 10(1):28-32 (2002)

Related Links